Tokyo Tape
Sign in
← Sundrug

Quarterly report · Q1

9989.TEDINET S100ROPZ
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥182.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥690.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥166.5bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥9.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥9.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥10.1bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥38.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥9.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥10.1bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥9.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥6.9bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥25.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.9bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥353.5bnat 2023-06-30Cons.Assets
Total assets¥360.7bnat 2023-03-31Cons.Assets
Total assets¥326.3bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥116.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥124.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥237.4bnat 2023-06-30Cons.Net assets
Net assets / equity¥236.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥222.7bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥68.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥80.9bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥59.022023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥219.832022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.872022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥59.012023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥219.822022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥53.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio67.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio65.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥13.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥13.1bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2023-04-01 → 2023-06-30¥75.9bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2023-04-01 → 2023-06-30¥75.9bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥2m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2023-04-01 → 2023-06-30¥119.3bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2023-04-01 → 2023-06-30¥106.2bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥13.1bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2023-04-01 → 2023-06-30¥6.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥195.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥182.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥13.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥9.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥12.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥12.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-06-30¥108.5bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥96.1bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥5.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥178.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥166.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥9.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 333
ItemContextValueUnit
Current liabilitiesPrior1YearInstant113249000000JPY
Current liabilitiesCurrentQuarterInstant104979000000JPY
Provision for directors retirement benefitsPrior1YearInstant303000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant306000000JPY
Net defined benefit liabilityPrior1YearInstant1993000000JPY
Net defined benefit liabilityCurrentQuarterInstant2035000000JPY
Asset retirement obligations nclPrior1YearInstant6156000000JPY
Asset retirement obligations nclCurrentQuarterInstant6201000000JPY
Other nclPrior1YearInstant2641000000JPY
Other nclCurrentQuarterInstant2607000000JPY
Noncurrent liabilitiesPrior1YearInstant11095000000JPY
Noncurrent liabilitiesCurrentQuarterInstant11151000000JPY
LiabilitiesPrior1YearInstant124344000000JPY
LiabilitiesCurrentQuarterInstant116130000000JPY
Capital stockPrior1YearInstant3931000000JPY
Capital stockCurrentQuarterInstant3931000000JPY
Capital surplusPrior1YearInstant7430000000JPY
Capital surplusCurrentQuarterInstant7430000000JPY
Retained earningsPrior1YearInstant230658000000JPY
Retained earningsCurrentQuarterInstant231712000000JPY
Treasury stockPrior1YearInstant-3940000000JPY
Treasury stockCurrentQuarterInstant-3940000000JPY
Shareholders equityPrior1YearInstant238080000000JPY
Shareholders equityCurrentQuarterInstant239134000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant82000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant98000000JPY
Revaluation reserve for landPrior1YearInstant-1805000000JPY
Revaluation reserve for landCurrentQuarterInstant-1805000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-58000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-54000000JPY
Valuation and translation adjustmentsPrior1YearInstant-1781000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-1761000000JPY
Subscription rights to sharesPrior1YearInstant29000000JPY
Subscription rights to sharesCurrentQuarterInstant31000000JPY
Net assetsPrior1YearInstant236328000000JPY
Net assetsCurrentQuarterInstant237404000000JPY
Liabilities and net assetsPrior1YearInstant360672000000JPY
Liabilities and net assetsCurrentQuarterInstant353534000000JPY
Net salesPrior1YTDDuration166455000000JPY
Net salesCurrentYTDDuration182146000000JPY
Cost of salesPrior1YTDDuration126443000000JPY
Cost of salesCurrentYTDDuration136926000000JPY
Gross profitPrior1YTDDuration40012000000JPY
Gross profitCurrentYTDDuration45219000000JPY
Selling general and administrative expensesPrior1YTDDuration30954000000JPY
Selling general and administrative expensesCurrentYTDDuration35319000000JPY
Operating incomePrior1YTDDuration9058000000JPY
Operating incomeCurrentYTDDuration9899000000JPY
Interest income noiPrior1YTDDuration24000000JPY
Interest income noiCurrentYTDDuration29000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass